XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This item clarifies what constitutes the fee schedule for the Dividend Aristocrats Etf and how each fee contributes to total costs.
11,557 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
As the S&P 500 faltered in early 2026, the Simplify Managed Futures Strategy ETF (CTA) posted gains, highlighting a h...
FELG has fallen about 8% year-to-date as megacap tech leads a broad pullback in growth stocks. The ETF tracks fidelit...
Bitcoin jumped to an intraday high near $82,000 on Thursday after a Senate committee advanced the Clarity Act, then e...
Bitcoin slipped below a key resistance area, opening a test of a critical support confluence around $70k-$72k. Analys...
Bitcoin remains resilient as ETF outflows accelerate and geopolitical headlines swirl. A new Chainlink-Kraken World C...
Two popular ETFs divide energy exposure: XOP tracks producers, while OIH tracks oil services. This piece breaks down ...
Backlog in the commercial space economy just reached a pivotal $500 billion mark as SpaceX began trading on NASDAQ, s...
Bitcoin pulled back from intraday highs as Iran's strikes in the Middle East sparked risk-off sentiment. the bitcoin ...
AI-driven projections point to XRP testing the $3.50 level as Bitcoin steadies. ETF inflows, Ripple's institutional p...
A wave of headlines claims cramer says trillion-dollar stocks are the must-watch trend. This article breaks down what...
Jim Cramer’s blunt message for 2026 is clear: if you only tech stocks, you’re taking on unnecessary risk. This articl...